CYTODROX (HYDROXYUREA)500MG – 100 tablet

$49.56

Each Cytodrox contains 500 mg Hydroxyurea 100 tablets. It is used to treat a type of leukemia and cancer of the head and neck and sickle cell anemia.

Active Ingrediant: HYDROXYUREA
Generic Name: CYTODROX
Manufacturer: Cipla Limited
Strength: 500MG
Dosage Type: Capsule
Packaging Type: Foil
Contains: 100 Cap

Inquire Us

Hydroxyurea Information

Pronunciation

hye droks ee yoor EE a

What is this drug used for?

• It is used to treat a type of leukemia.
• It is used to treat cancer of the head and neck.
• It is used to treat sickle cell anemia.
• It may be given to you for other reasons. Talk with the doctor.

Frequently reported side effects of this drug

• Hair loss
• Nausea
• Lack of appetite
• Constipation
• Diarrhea
• Weight gain
• Headache
• Mouth sores

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Infection
• Mole changes
• Skin growths

• Severe pulmonary disorder like lung or breathing problems like difficulty breathing, shortness of breath, or a cough that is new or worse

• Bruising
• Bleeding
• Severe loss of strength and energy
• Skin ulcers
• Skin changes
• Nail changes
• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Medication Safety Issues

Sound-alike/look-alike issues:

Hydrea may be confused with Lyrica
Hydroxyurea may be confused with hydroxychloroquine, hydrOXYzine

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.

International issues:

Hydrea [US, Canada, and multiple international markets] may be confused with Hydra brand name for isoniazid [Japan]

Product Availability

Siklos 100 mg functionally scored tablets: FDA approved May 2019; anticipated availability is currently unknown. Consult the prescribing information for additional information.

Storage and Stability

Droxia, Hydrea: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Keep bottle tightly closed.
Siklos: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Keep bottle tightly closed; use split tablets within 3 months.

Adverse Reactions

Central nervous system: Headache, severe nervous system disease

Dermatologic: Dermal ulcer (Antonioli 2012), dermatological reaction, eczema (infants and children [Thornburg 2012]), leg ulcer (Hernández-Boluda 2011), skin depigmentation
Endocrine & metabolic: Vitamin D deficiency, weight gain

Gastrointestinal: Acute mucocutaneous toxicity (Hernández-Boluda 2011), constipation, gastric distress (infrequent [Antonioli 2012]), gastritis, nausea, oral mucosa ulcer (infrequent [Hernández-Boluda 2011])

Genitourinary: Urinary tract abnormality
Hematologic & oncologic: Anemia, bone marrow depression (recovery: within 2 weeks), hemorrhage, leukemia, leukopenia, macrocytosis (MCV >97 [Randi 2005]), neutropenia, thrombocytopenia

Infection: Bacterial infection, infection, parvovirus B19 seroconversion, viral infection
Neuromuscular & skeletal: Panniculitis (Antonioli 2012)
Renal: Renal disease
Respiratory: Asthma (infants and children [Thornburg 2012])
Miscellaneous: Fever